Hansen HJ - Search Results

1

CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.

Govindan SV, Cardillo TM, Moon SJ, Hansen HJ, Goldenberg DM. Govindan SV, et al. Among authors: hansen hj. Clin Cancer Res. 2009 Oct 1;15(19):6052-61. doi: 10.1158/1078-0432.CCR-09-0586. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789330 Free PMC article.

2

Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy.

Rossi EA, Sharkey RM, McBride W, Karacay H, Zeng L, Hansen HJ, Goldenberg DM, Chang CH. Rossi EA, et al. Among authors: hansen hj. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3886S-96S. Clin Cancer Res. 2003. PMID: 14506187

3

Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.

Griffiths GL, Mattes MJ, Stein R, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Griffiths GL, et al. Among authors: hansen hj. Clin Cancer Res. 2003 Dec 15;9(17):6567-71. Clin Cancer Res. 2003. PMID: 14695162

4

Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel.

Govindan SV, Stein R, Qu Z, Chen S, Andrews P, Ma H, Hansen HJ, Griffiths GL, Horak ID, Goldenberg DM. Govindan SV, et al. Among authors: hansen hj. Breast Cancer Res Treat. 2004 Mar;84(2):173-82. doi: 10.1023/B:BREA.0000018417.02580.ef. Breast Cancer Res Treat. 2004. PMID: 14999147

5

Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.

Stein R, Govindan SV, Hayes M, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM. Stein R, et al. Among authors: hansen hj. Clin Cancer Res. 2005 Apr 1;11(7):2727-34. doi: 10.1158/1078-0432.CCR-04-2100. Clin Cancer Res. 2005. PMID: 15814655

6

Development of humanized antibodies as cancer therapeutics.

Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Qu Z, et al. Among authors: hansen hj. Methods. 2005 May;36(1):84-95. doi: 10.1016/j.ymeth.2005.01.008. Methods. 2005. PMID: 15848077

7

Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies.

Govindan SV, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM. Govindan SV, et al. Among authors: hansen hj. Technol Cancer Res Treat. 2005 Aug;4(4):375-91. doi: 10.1177/153303460500400406. Technol Cancer Res Treat. 2005. PMID: 16029057 Free article. Review.

8

Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.

Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM. Sapra P, et al. Among authors: hansen hj. Clin Cancer Res. 2005 Jul 15;11(14):5257-64. doi: 10.1158/1078-0432.CCR-05-0204. Clin Cancer Res. 2005. PMID: 16033844

9

Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells.

Rossi EA, Chang CH, Losman MJ, Sharkey RM, Karacay H, McBride W, Cardillo TM, Hansen HJ, Qu Z, Horak ID, Goldenberg DM. Rossi EA, et al. Among authors: hansen hj. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7122s-7129s. doi: 10.1158/1078-0432.CCR-1004-0020. Clin Cancer Res. 2005. PMID: 16203811

10

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).

Blumenthal RD, Hansen HJ, Goldenberg DM. Blumenthal RD, et al. Among authors: hansen hj. Cancer Res. 2005 Oct 1;65(19):8809-17. doi: 10.1158/0008-5472.CAN-05-0420. Cancer Res. 2005. PMID: 16204051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page